$101 Thousand is the total value of PERKINS CAPITAL MANAGEMENT INC's 98 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 11.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AUGX | Sell | Augmedix Inc | $7,164 | -3.3% | 1,391,093 | -9.7% | 7.10% | +10.0% |
| LLY | Sell | Eli Lilly & CO | $7,000 | +14.5% | 13,032 | -0.1% | 6.94% | +30.2% |
| Sell | Perion Network Ltd | $2,938 | -1.1% | 95,935 | -1.0% | 2.91% | +12.5% | |
| NTRA | Sell | Natera Inc | $2,740 | -9.5% | 61,925 | -0.4% | 2.72% | +3.0% |
| VCYT | Sell | Veracyte Inc | $2,672 | -13.5% | 119,680 | -1.4% | 2.65% | -1.6% |
| PFIE | Sell | Profire Energy Inc | $2,527 | +51.8% | 909,080 | -32.8% | 2.50% | +72.6% |
| NEO | Sell | NeoGenomics Inc | $2,386 | -24.4% | 193,950 | -1.3% | 2.36% | -14.1% |
| ATEC | Sell | Alphatec Hldgs Inc | $2,235 | -28.6% | 172,317 | -1.0% | 2.22% | -18.8% |
| OOMA | Sell | Ooma Inc | $1,892 | -13.2% | 145,450 | -0.1% | 1.88% | -1.3% |
| DGII | Sell | Digi IntL Inc | $1,783 | -32.3% | 66,033 | -1.2% | 1.77% | -23.0% |
| ABBV | Sell | AbbVie Inc | $1,618 | +9.1% | 10,858 | -1.4% | 1.60% | +24.1% |
| PFE | Sell | Pfizer Inc | $1,600 | -9.8% | 48,241 | -0.2% | 1.59% | +2.7% |
| STRM | Sell | Streamline Health Solutions | $1,447 | -26.2% | 1,495,405 | -3.1% | 1.44% | -16.0% |
| INUV | Sell | Inuvo Inc | $1,347 | -4.1% | 6,294,207 | -0.6% | 1.34% | +9.1% |
| FPAY | Sell | FlexShopper Inc | $1,322 | -19.5% | 1,265,040 | -1.4% | 1.31% | -8.4% |
| ATRC | Sell | AtriCure Inc | $1,286 | -14.2% | 29,350 | -3.3% | 1.28% | -2.3% |
| TCMD | Sell | Tactile Sys Technology Inc | $1,170 | -43.7% | 83,300 | -0.1% | 1.16% | -35.9% |
| VCEL | Sell | Vericel Corp | $1,073 | -13.1% | 32,000 | -2.6% | 1.06% | -1.1% |
| GILD | Sell | Gilead Sciences Inc | $1,018 | -3.0% | 13,583 | -0.2% | 1.01% | +10.4% |
| ISR | Sell | Perspective Therapuetics Inc | $731 | -59.1% | 2,671,644 | -0.1% | 0.72% | -53.4% |
| APYX | Sell | Apyx Medical CorpORATION | $678 | -37.6% | 211,800 | -1.9% | 0.67% | -29.0% |
| Sell | Journey Med Corp | $615 | +70.8% | 224,295 | -0.9% | 0.61% | +94.3% | |
| PLUS | Sell | EPlus Inc | $603 | +2.0% | 9,500 | -9.5% | 0.60% | +16.1% |
| Sell | Achieve Life Sciences Inc | $538 | -17.9% | 125,212 | -0.8% | 0.53% | -6.7% | |
| AZYO | Sell | Elutia Inc | $496 | -39.8% | 347,198 | -0.5% | 0.49% | -31.5% |
| CSTL | Sell | Castle Biosciences Inc | $493 | +17.4% | 29,160 | -4.7% | 0.49% | +33.6% |
| OPCH | Sell | Option Care Health Inc | $404 | -14.2% | 12,500 | -13.8% | 0.40% | -2.2% |
| JNJ | Sell | Johnson & Johnson | $350 | -8.1% | 2,250 | -2.2% | 0.35% | +4.5% |
| PRFT | Sell | Perficient Inc | $260 | -37.6% | 4,500 | -10.0% | 0.26% | -28.9% |
| IONS | Sell | Ionis Pharmaceuticals Inc | $252 | +8.6% | 5,550 | -1.8% | 0.25% | +23.8% |
| IMGN | Sell | Immunogen Inc | $192 | -40.9% | 12,100 | -29.7% | 0.19% | -32.9% |
| Sell | Rockwell Med Inc | $156 | -64.3% | 75,043 | -6.2% | 0.16% | -59.3% | |
| ARAY | Sell | Accuray Inc | $124 | -39.5% | 45,500 | -14.2% | 0.12% | -31.3% |
| IRIX | Sell | Iridex Corp | $102 | -6.4% | 40,250 | -20.2% | 0.10% | +6.3% |
| BTTR | Sell | Better Choice Co INC | $97 | -46.1% | 782,834 | -8.5% | 0.10% | -38.9% |
| SENS | Sell | Senseonics HLDGS Inc | $47 | -42.7% | 77,500 | -27.6% | 0.05% | -33.8% |
| AMRN | Sell | Amarin Corp PLCspons adr new | $21 | -30.0% | 22,500 | -11.8% | 0.02% | -19.2% |
| VVOS | Sell | Vivos Therapeutics Inc | $3 | -70.0% | 15,000 | -26.8% | 0.00% | -66.7% |
| IMBI | Exit | IMEDIA BRANDS INC | $0 | – | -35,700 | -100.0% | -0.00% | – |
| Exit | BIOLASE INC | $0 | – | -157,196 | -100.0% | -0.01% | – | |
| VRAY | Exit | VIEWRAY INC | $0 | – | -62,300 | -100.0% | -0.02% | – |
| PRTK | Exit | PARATEK PHARMACEUTICALS INC | $0 | – | -13,700 | -100.0% | -0.03% | – |
| FBIO | Exit | FORTRESS BIOTECH INC | $0 | – | -1,419,013 | -100.0% | -0.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEOGENOMICS INC | 41 | Q3 2023 | 7.8% |
| LILY ELI & CO | 41 | Q3 2023 | 6.9% |
| PFIZER INC | 41 | Q3 2023 | 2.9% |
| ATTUNITY LTD | 41 | Q3 2023 | 3.6% |
| EXPEDITORS INTL WASH INC | 41 | Q3 2023 | 2.3% |
| CVS HEALTH CORP | 41 | Q3 2023 | 1.6% |
| DONALDSON INC | 41 | Q3 2023 | 1.3% |
| VERIZON COMMUNICATIONS INC | 41 | Q3 2023 | 1.0% |
| US BANCORP DEL | 41 | Q3 2023 | 0.8% |
| BAXTER INTL INC | 40 | Q3 2023 | 14.1% |
View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BIOLASE, INC | May 15, 2023 | 689,196 | 2.1% |
| FlexShopper, Inc. | February 09, 2023 | 1,281,460 | 5.9% |
| Avinger Inc | February 14, 2020 | 891,761 | 5.2% |
| Black Ridge Oil & Gas, Inc. | February 15, 2019 | 30,021,032 | 6.3% |
| CANCER GENETICS, INC | February 15, 2019 | 1,135,250 | 4.0% |
| TearLab Corp | February 15, 2019 | 1,666,294 | 13.1% |
| Xtant Medical Holdings, Inc. | February 15, 2019 | 684,408 | 3.6% |
| TearLab Corp | January 26, 2018 | 4,300,655 | 40.1% |
| BIO KEY INTERNATIONAL INC | February 09, 2017 | 274,900 | 4.4% |
| EnteroMedics Inc | February 09, 2017 | 1,455 | 0.0% |
View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-09 |
| 13F-HR | 2024-01-22 |
| 13F-HR | 2023-11-02 |
| 13F-HR | 2023-07-21 |
| SC 13G/A | 2023-05-15 |
| 13F-HR | 2023-05-09 |
| SC 13G/A | 2023-02-09 |
| SC 13G | 2023-02-09 |
| 13F-HR | 2023-01-26 |
| 13F-HR | 2022-10-24 |
View PERKINS CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.